Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430204 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 1,628
- Enrollment target
NCT05430204: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT05430204 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,628 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05430204, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,628 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compared to usual care
Primary Outcome
Composite adverse neonatal outcome include one or more of the following: * Large for Gestational Age(LGA) is described as weight over 90th percentile of the expected value according to gestational age (using the nomogram by Duryea EL et al) * Shoulder Dystocia is defined as the need for any extra maneuvers, other than gentle downward traction of the fetal head to deliver the fetal body after the fetal head has been delivered * Birth injury: skull, clavicular, humerus fracture, or brachial plexu
Interventions
- DEVICE Group 1: one-hour GCT
- DEVICE Group 2: CGM placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,628 participants |
| Start Date | 2023-03-07 |
| Est. Completion | 2024-09-16 |
| Phase | NA |
What the finished NCT05430204 record still lists
NCT05430204 is an interventional study that assigns participants to a tested intervention. Its 1,628 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher).
The record links to 0 conditions, and to 2 interventions - of which Group 1: one-hour GCT is the first listed.
NCT05430204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05430204 about?
NCT05430204 is a clinical study titled "Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy". The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compa...
What is the current status of trial NCT05430204?
This trial is currently completed. It is a NA study. The enrollment target is 1,628 participants. The study started on 2023-03-07. Estimated completion is 2024-09-16.
What interventions are being tested in trial NCT05430204?
The interventions under investigation include: Group 1: one-hour GCT (DEVICE), Group 2: CGM placement (DEVICE).
Who is sponsoring clinical trial NCT05430204?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05430204's enrollment target sits among peer trials
1,628 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI